首页> 外文期刊>Journal of the Science of Food and Agriculture >Stability of a soybean seed-derived vaccine antigen following long-term storage, processing and transport in the absence of a cold chain
【24h】

Stability of a soybean seed-derived vaccine antigen following long-term storage, processing and transport in the absence of a cold chain

机译:在没有冷链的情况下长期储存,加工和运输后,大豆种子衍生的疫苗抗原的稳定性

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Soybean seeds are rich in natural protein and are favorable environments for targeted protein expression. Soybeans represent an ideal platform for the production of novel vaccines that, in theory, do not require a cold chain. This study investigated the stability of a soybean-derived antigen following long-term storage, formulation, and shipment overseas in the absence of refrigeration.RESULTS: Transgenic seeds can be stored for more than 4 years at ambient temperature with no detectable loss of FanC antigen stability. Conventional processing methods utilizing heat, mechanical extraction and solvent extraction resulted in practical formulations that could be lyophilized, stored as dried milk powder and rehydrated in water without loss of FanC antigen stability. Overseas shipment of transgenic seed powder and soymilk formulations in the absence of a cold chain had no adverse effects on formulations or the FanC antigen.CONCLUSION: The feasibility of long-term storage, processing and shipment of transgenic soy products in the absence of a cold chain was demonstrated. Soybeans represent a practical platform for development of novel vaccines to potentially address the worldwide need for vaccines that are cost-effective, easy to formulate and can be manufactured, stored and transported without refrigeration. Copyright
机译:背景:大豆种子富含天然蛋白质,是靶向蛋白质表达的有利环境。大豆代表生产理论上不需要冷链的新型疫苗的理想平台。这项研究调查了大豆衍生抗原在不冷藏的情况下长期储存,配制和运输到国外后的稳定性。结果:转基因种子可以在环境温度下保存4年以上,而不会检测到FanC抗原的丢失稳定性。利用热量,机械提取和溶剂提取的常规加工方法产生了可以冻干,以奶粉形式干燥并在水中复水的实用配方,而不会失去FanC抗原的稳定性。在不存在冷链的情况下将转基因种子粉和豆浆配制品海外运输对配制品或FanC抗原没有不利影响。结论:在不存在冷链的情况下长期储存,加工和运输转基因大豆产品的可行性链被演示。大豆是开发新型疫苗的实用平台,可以潜在地满足全球范围内对具有成本效益,易于配制并且可以在不冷藏的情况下进行制造,存储和运输的疫苗的需求。版权

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号